Page last updated: 2024-10-28

hexamethylene bisacetamide and Cancer of Prostate

hexamethylene bisacetamide has been researched along with Cancer of Prostate in 1 studies

N,N'-diacetyl-1,6-diaminohexane: chemical name obtained from Acta Biol Hung 1990;41(1-3):199-208

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lama, R1
Gan, C1
Idippily, N1
Bobba, V1
Danielpour, D1
Montano, M1
Su, B1

Other Studies

1 other study available for hexamethylene bisacetamide and Cancer of Prostate

ArticleYear
HMBA is a putative HSP70 activator stimulating HEXIM1 expression that is down-regulated by estrogen.
    The Journal of steroid biochemistry and molecular biology, 2017, Volume: 168

    Topics: Acetamides; Benzeneacetamides; Biotinylation; Breast Neoplasms; Cell Differentiation; Cell Line, Tum

2017